Pfizer Inc SEC filings PFE
Pfizer Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 26, 2021. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 27, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Oct 16, 2026 | Oct 15, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 16, 2026 | — |
| 4 | Insider transaction | Oct 14, 2026 | Oct 13, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| N-PX | Filing | Aug 31, 2026 | Jun 30, 2026 |
| 3 | Initial insider ownership | Aug 28, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| 13F-HR | Filing | Aug 13, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 6, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 28, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 15, 2026 |
| 4 | Insider transaction | Jul 13, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 11-K | Employee savings plan report | Jun 16, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 16, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| 13F-HR | Filing | May 12, 2026 | Mar 31, 2026 |
| S-8 | Employee stock plan registration | May 5, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 29, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2026 | — |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 3/A | Filing | Apr 27, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 13, 2026 |
| ARS | Annual report to shareholders | Mar 12, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 12, 2026 | — |
| DEF 14A | Proxy statement | Mar 12, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 13F-HR | Filing | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Other events
|
Nov 21, 2025 | Nov 18, 2025 |
| 424B5 | Prospectus supplement | Nov 20, 2025 | — |
| FWP | Free writing prospectus | Nov 19, 2025 | — |
| 424B3 | Prospectus | Nov 18, 2025 | — |
| 4 | Insider transaction | Nov 17, 2025 | Nov 14, 2025 |
| 13F-HR | Filing | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 28, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 16, 2025 | Oct 14, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 17, 2025 | Sep 15, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 13F-HR | Filing | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 29, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 16, 2025 | Jul 14, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 11-K | Employee savings plan report | Jun 16, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 16, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jun 3, 2025 | May 30, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 144 | Notice of proposed sale | May 23, 2025 | — |
| CERT | Nyse certification | May 20, 2025 | — |
| 8-A12B | Filing | May 19, 2025 | — |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| FWP | Free writing prospectus | May 14, 2025 | — |
| 13F-HR | Filing | May 13, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | May 13, 2025 | — |
| POSASR | Filing | May 13, 2025 | — |
| 144 | Notice of proposed sale | May 5, 2025 | — |
| 10-Q | Quarterly report | May 5, 2025 | Mar 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 28, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 14, 2025 | Apr 10, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| PX14A6G | Filing | Mar 25, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 24, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 20, 2025 | — |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PFE (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 78003
- Former names
- PFIZER INC (until Nov 3, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.